Clinical trial

Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance

NCT01156298

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2010-06-01

PhaseN/A

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2012-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01156298 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.